• 1. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 2. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 5. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Aminopyridines and derivatives

Recent Advances in the Study of 6-Aminopyridine-2-carbothioamide (CAS: 1342900-31-5)

6-Aminopyridine-2-carbothioamide (CAS: 1342900-31-5) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential therapeutic applications. Recent studies have focused on its role as a key intermediate in the synthesis of bioactive molecules, particularly those targeting enzyme inhibition and antimicrobial activity. This research brief aims to summarize the latest findings related to this compound, highlighting its chemical properties, biological activities, and potential applications in drug development.

One of the most notable advancements in the study of 6-Aminopyridine-2-carbothioamide is its application in the development of kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is often associated with various diseases, including cancer and inflammatory disorders. Recent research has demonstrated that derivatives of 6-Aminopyridine-2-carbothioamide exhibit potent inhibitory effects on specific kinases, such as JAK2 and EGFR, which are key targets in oncology. These findings suggest that this compound could serve as a promising scaffold for the design of novel kinase inhibitors.

In addition to its role in kinase inhibition, 6-Aminopyridine-2-carbothioamide has also been investigated for its antimicrobial properties. A study published in the Journal of Medicinal Chemistry reported that certain derivatives of this compound exhibit broad-spectrum activity against both Gram-positive and Gram-negative bacteria. The mechanism of action appears to involve the disruption of bacterial cell wall synthesis, making it a potential candidate for the development of new antibiotics. This is particularly relevant in the context of increasing antibiotic resistance, where novel antimicrobial agents are urgently needed.

Another area of interest is the compound's potential application in neurodegenerative diseases. Preliminary studies have shown that 6-Aminopyridine-2-carbothioamide derivatives can modulate the activity of enzymes involved in neurotransmitter metabolism, such as monoamine oxidase (MAO). This modulation could have therapeutic implications for conditions like Parkinson's disease and depression. However, further in vivo studies are required to validate these findings and assess the compound's safety profile.

The synthesis and optimization of 6-Aminopyridine-2-carbothioamide derivatives have also been a focus of recent research. Advances in synthetic chemistry have enabled the development of more efficient and scalable methods for producing these compounds. For instance, a recent study utilized microwave-assisted synthesis to achieve higher yields and shorter reaction times, which could facilitate the large-scale production of these molecules for further biological testing.

Despite these promising developments, challenges remain in the clinical translation of 6-Aminopyridine-2-carbothioamide-based therapeutics. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through comprehensive preclinical studies. Nevertheless, the compound's versatility and demonstrated biological activities make it a valuable candidate for future drug discovery efforts.

In conclusion, 6-Aminopyridine-2-carbothioamide (CAS: 1342900-31-5) represents a versatile and promising scaffold in medicinal chemistry. Its applications span from kinase inhibition to antimicrobial activity and potential neuroprotective effects. Continued research and optimization of this compound and its derivatives could lead to the development of novel therapeutics for a range of diseases. Future studies should focus on addressing the current limitations and exploring its full therapeutic potential.

• 5346-38-3(Pyridine-2-carbothioamide)
• 1881329-18-5(6-(Aminomethyl)pyridin-2-amine dihydrochloride)
• 380394-86-5(6-(Aminomethyl)pyridin-2-amine trihydrochloride)
• 167298-54-6(6-(aminomethyl)pyridin-2-amine)
• 61574-17-2(Pyridinecarbothioamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)